Epistem provides specialised in vitro and in vivo preclinical services in oncology, inflammatory diseases, skin, wound healing and gastrointestinal disorders. Epistem’s proactive approach to solving complex problems and advancing biotechnology, coupled with a steadfast commitment to meeting regulatory standards, underscores Epistem’s dedication to driving positive change in the industry. Supported by GCLP-accredited analytical platform for clinical samples, Epistem’s dedication to excellence is demonstrated through tailored solutions crafted by an experienced and determined team.
Epistem is committed to delivering the highest quality services and support to Epistem’s clients, every step of the way.
